A single-site randomized controlled trial of partner navigation to HCV treatment for people who inject drugs: a study protocol for the You’re Empowered for Treatment Initiation (YETI) partner trial“This trial will provide evidence of a new HCV treatment linkage...
Protecting Medicaid for People with Lung Cancer“When Wynn first went to the hospital for a collapsed lung, she didn’t have health insurance and believed that she did not get the care she needed. Doctors did an x-ray and dealt with the immediate problem, but did not...
Alcohol-Associated Liver Disease, MASLD Drive Growing Liver Cancer Burden in the US“Key Takeaways: Primary liver cancer in the US has increased significantly, driven by ALD and MASLD, with a 142% rise in prevalence from 2000 to 2021. Hepatitis C virus remains the...
A ‘perfect storm’ of mutations: How chronic hepatitis C infection leads to autoimmune disease“Scientists at the Garvan Institute of Medical Research have discovered how a viral infection causes autoimmune disease, disproving a long-standing theory and...
Datopotamab Deruxtecan Granted Priority Review in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer “TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq:...
More News and Updates